KALV
KalVista Pharmaceuticals, Inc. · Healthcare
CEO Thomas Andrew Crockett sold $351K of KalVista Pharmaceuticals, Inc.
Sold$351,289
$14.11Price
24,888Shares
−11%Stake
What KALV did after the filing
- The stock from Thu, Feb 22 open, $13.11
- −15.4%
- S&P 500, same days
- +3.2%
Measured over 30 trading days, to the Apr 5 close.
Traded Tue, Feb 20. Filed Wed, Feb 21, 4:41 PM ET, after the close. Returns use the Feb 22 open and the Apr 5 close. Not investment advice.